82
Views
26
CrossRef citations to date
0
Altmetric
Paper

Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings

, &
Pages 539-545 | Received 02 Sep 2002, Accepted 19 Dec 2002, Published online: 03 Jul 2009

References

  • AIUMOTO, T., HUNTER, N. R., BucHmuLER, L., MASON, K., ANG, K. K. and MILAS, L., 1999, Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clinical Cancer Research, 5, 2884–2890.
  • ANG, K. K., BERKEY, B. A., Tu, X., ZHANG, H. Z., KATz, R., HAMMOND, E. H., Fu, K. K. and Mu, As, L., 2002, Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Research, 62, 7350–7356.
  • BALABAN, N., MONT, J., SHANNON, M., DG, L., MURPHY, K. E. and GOLDKORN, T., 1996, The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochimica et Biophysica Acta, 1314, 147–156.
  • BANDYOPADHYAY, D., MANDAL, M., ADAM, L., MENDELSOHN, J. and KUMA RR., 1998, Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. Journal of Biological Chemistry, 273, 1568–1573.
  • BIANCO, C., BIANCO, R., TORTORA, G., DAMIAN°, V., GUERRIERI, P., MONTEMAGGI, P., MENDELSOHN, J., DE PLACID°, S., BIANCO, A. R. and CIARDIELLO, F., 2000, Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. Clinical Cancer Research, 6, 4343–4350.
  • DICKSTEIN, B. N., WosuwwsKi, K. and BATE SS., 1995, Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor. Molecular and Cellular Endocrinology, 110, 205–211.
  • GTLIF, J., SWERLICK, R. A. and CAUGHIVIAN, S. W., 1997, Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/ VEGF) gene requires AP-2 dependent DNA binding and transactivation. EMBO Journal, 16, 750–759.
  • GOLDKORN, T., BALABAN, N., SHANNON, M. and MATSUKUMA, K., GTT.T.F, 1997, EGF receptor phosphorylation is affected by ionizing radiation. Cancer Research, 59, 3374–3378.
  • GORSKI, D. H., BEcKETE M. A., JASKOWIAK, N. T., CALVIN, D. P., MAUCERI, H. J., SALLOUM, R. M. SEETHARAM, S., KOONS, A., HAM, D. M., KUFE, D. W. and WEISCHSELBAUM, R. R., 1999, Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Research, 59, 3374–3378.
  • GORSKI, D. H., MAUCERI, H. J., SALLOUM, R. M., GATELY, S HELLMAN, S BECKETT', M. A., SUKHATME, V. P., SOFF, G. A., KUFE, D. W. and WEICHSELBAUM, R. R., 1998, Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Research, 58, 5686–5689.
  • HUANG, S. -M., BocK, J. M. and HARARI, P. M., 1999, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Research, 59, 1935–1940.
  • HUANG, S. M. and HARARI, P. M., 2000, Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clinical Cancer Research, 6, 2166–2174.
  • KATAYOSE, Y., KIM, M., RAKKAR, A. N. S., Li, Z. W., Cow, K. H. and SETH, P., 1997, Promoting apoptosis: a novel activity associated with the cycle-dependent kinase inhibitor p27. Cancer Research, 57, 5441–5445.
  • KELMAN, Z., 1997, PCNA: structure, functions and interactions. Oncogene, 4, 629–640.
  • EIANG, K., ANG, K. K., MuAs, L., HUNTER, N. and FAN, Z., in press, Increased raclioresistance of OCA-I mouse ovarian carcinoma cells expressing human epidermal growth factor receptor. International journal of Radiation, Oncology, Biology and Physics.
  • MAUCERI, H. J., HANNA, N. N., BECKETT, M. A., GORSKI, D. H., STABA, M. J., STELLATO, K. A., BIGELOW, K., HEIMANN, R., GATELY, S. DHANABAL, M., SOFF, G. A., SUKHATME, V. P., KUFE, D. W. and WEICHSELBAUM, R. R., 1998, Combined effects of angiostatin and ionizing radiation in antitumor therapy. Nature, 394, 287–291.
  • MENDELSOHN, J., 2000, Blockade of receptors for growth factors: an anticancer therapy. The Fourth Annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Award Lecture. Clinical Cancer Research, 6, 747–753.
  • MENDELSOHN, J. and FAN, Z., 1997, Epidermal growth factor receptor family and chemosensitization. Journal of National Cancer Institute, 89, 341–343.
  • MuAs, L., AKIMOTO, T., HUNTER, N. R., GUITENBERGER, R. and THAMES, H. D., 2002, Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas. International Journal of Radiation, Oncology, Biology, and Physics, 52, 514–421.
  • MuAs, L., FAN, Z., MASON, K. A. and ANG, K. K., 2003, Role of epidermal growth factor receptor (EGFR) and its inhibition in radiotherapy. In C. Nieder, L. Milas and K. K. Ang (eds), ModOcation of Radiation Response (Heidelberg: Springer), pp. 189–204.
  • MHAS, L., MASON, K., HUNTER, N., PETERSEN, S. YAMAKAW, M., ANG, K. K., MENDELSOHN, J. and FAN, Z., 2000, In vivo enhancement of tumor raclioresponse by C225 antiepidermal growth factor receptor antibody. Clinical Cancer Research, 6, 701–708.
  • MHAS, L., YAMADA, S., HUNTER, N., YAMADA, S., HUNTER, N., GUITENBERGER, R. and THAMES, H. D., 1991, Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirracliated tumors. International Journal of Radiation, Oncology, Biology, and Physics, 21, 1195–1202.
  • NASU, S., MG, K. K., FAN, Z. and MILAS, L., 2001, C225 antiepidermal growth factor receptor antibody enhances tumor racliocurability. International Radiation, Oncology, Biology, and Physics, 51, 474–477.
  • PEEoTrE, P., MATSUMOTO, T., INouE, K., KuNwAsu, H., EVE, B. Y., HICKLIN, D. J., RADINSKY, R. and DINNEY, C. P., 1999, Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clinical Cancer Research, 5, 257–265.
  • RurFEoK, A. and McBErDE, W., 1999, Growth factors: biological and clinical aspects. International Journal of Radiation, Oncology, Biology and Physics, 43, 877–881.
  • SCIEVIIDT-ULLRICH, R. K., DENT, P., GRANT, S MIKKELSEN, R. B. and VALERIE, K., 2000, Signal transduction and cellular radiation responses. Radiation Research, 153, 245–257.
  • SC HMIDT-ULLRIC H, R. K., MIKKELSEN, R. B., DENT, P., TODD, D. G., VALERIE, K., KAVANAGH, B. D., C ONTESSA, J. N., ROARER, W. K. and CHEN, R. B., 1997, Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene, 15, 1191–1197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.